Medicare Enrolled

Dr. Amadi Rezai, MD

Optician · Manahawkin, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
602 ROUTE 72 EAST, Manahawkin, NJ 08050
6099789870
In practice since 2006 (20 years)
NPI: 1487602116 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rezai from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rezai? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rezai

Dr. Amadi Rezai is an optician specialist in Manahawkin, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rezai performed 471 Medicare services across 419 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rezai received a total of $3,888 from 39 pharmaceutical and/or device companies across 255 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rezai is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 471 Medicare services $3,888 industry payments

Medicare Practice Summary

Medicare Utilization ↗
471
Medicare services
Bottom 32% in NJ for optician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
419
Unique beneficiaries
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~24 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
142 $69 $552
Pelvic and clinical breast exam for cancer screening
A physical examination of the pelvis and breasts to screen for cervical or vaginal cancer. This procedure involves a clinical assessment performed by a healthcare provider.
124 $43 $241
Pap smear screening test
A screening test to collect and prepare a cervical or vaginal sample for laboratory analysis.
110 $48 $298
Complete pelvic ultrasound
An imaging test using sound waves to create pictures of the organs and structures within the pelvis.
37 $88 $671
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
34 $97 $782
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
24 $73 $544
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,888
Total received (2018-2024)
Avg $555/year across 7 years
Top 21% in NJ for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
255
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,736 (96.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$152 (3.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$855
2023
$886
2022
$846
2021
$321
2020
$183
2019
$376
2018
$419

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Sumitomo Pharma America, Inc.
$178
Astellas Pharma US Inc
$163
Sage Therapeutics, Inc.
$75
MAYNE PHARMA COMMERCIAL LLC
$75
Exeltis, USA Inc.
$69
Daiichi Sankyo Inc.
$56
Amgen Inc.
$53
PFIZER INC.
$51
Hologic Sales and Service, LLC
$49
Smith+Nephew, Inc.
$37
Organon Llc
$33
Evofem Biosciences, Inc.
$17
Top 3 companies account for 48.6% of 2024 payments
All-time payments by company (2018-2024) ›
Daiichi Sankyo Inc.
$389
Sumitomo Pharma America, Inc.
$313
ABBVIE INC.
$312
Astellas Pharma US Inc
$271
Exeltis, USA Inc.
$217
Hologic, LLC
$153
MAYNE PHARMA COMMERCIAL LLC
$153
AMAG Pharmaceuticals, Inc.
$152
Medtronic, Inc.
$150
Amgen Inc.
$149
Roche Diagnostics Corporation
$139
Myovant Sciences Inc.
$127
PFIZER INC.
$126
Hologic Sales and Service, LLC
$125
AbbVie Inc.
$118
AbbVie, Inc.
$118
Lupin Inc.
$105
Sage Therapeutics, Inc.
$75
MAYNE PHARMA INC.
$74
Radius Health, Inc.
$71
Evofem Biosciences, Inc.
$71
TherapeuticsMD, Inc.
$54
Avion Pharmaceuticals
$51
Exact Sciences Corporation
$45
Smith+Nephew, Inc.
$37
Allergan Inc.
$36
Organon Llc
$33
Bayer HealthCare Pharmaceuticals Inc.
$31
Agile Therapeutics, Inc.
$29
Merck Sharp & Dohme Corporation
$29
Duchesnay USA Incorporated
$27
Organon LLC
$18
SI-BONE, INC.
$16
MILLICENT US INC
$14
CooperSurgical, Inc.
$13
COVIDIEN LP
$13
Allergan, Inc.
$12
Minerva Surgical, Inc
$12
Vertical Pharmaceuticals, LLC
$12
Top 3 companies account for 26.1% of all-time payments
Associated products mentioned in payments ›
ACESSA PROVU SYSTEM · ANNOVERA · APTIMA · BIJUVA · Balcoltra · CINtec PLUS Cytology · ClosureFast · Cologuard Collection Kit · EVENITY · FLUENT FLUID MANAGEMENT SYSTEM · Femring · Fluent · GEMTESA · IFUSE IMPLANT · IMVEXXY · INJECTAFER · INTRAROSA · JADA SYSTEM · Kyleena · LILETTA · LO LOESTRIN FE · MAKENA · MD cobas Instruments and Reagents · MYFEMBREE · MYOSURE TISSUE REMOVAL DEVICE · MYRBETRIQ · MyoSure · Myrbetriq · NEXPLANON · NOVASURE · NovaSure · Novasure · ORIAHNN · ORILISSA · Orilissa · Osphena · PICO 7 · PREMARIN · Phexxi · Prenate Mini · Prolia · SLYND · SOLOSEC · SOLOSEC-CEEK · TRUCLEAR · TruClear · Twirla · Tymlos · Uterine Manipulators & Injectors · VESICARE · VYLEESI · Veozah · Vesicare · ZURZUVAE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an optician specialist in Manahawkin?
Compare opticians in the Manahawkin area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
70
Per 100K population
10.8
County median income
$86,411
Nearest hospital
SOUTHERN OCEAN MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Rezai is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Rezai experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Rezai performed 142 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rezai receive payments from pharmaceutical companies?
Yes. Dr. Rezai received a total of $3,888 from 39 companies across 255 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rezai's costs compare to other opticians in Manahawkin?
Dr. Rezai's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rezai) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →